PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma

NCT00054665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

B-Cell Lymphoma

Interventions

DRUG: PS-341
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Filgrastim

Sponsor

National Cancer Institute (NCI)